Insider Transactions in Q1 2025 at Computer Programs & Systems Inc (CPSI)
Insider Transaction List (Q1 2025)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Mar 17
2025
|
Dawn M Severance Chief Sales Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,122
-3.54%
|
$31,416
$28.1 P/Share
|
Mar 17
2025
|
Vinay Bassi Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,965
-8.35%
|
$111,020
$28.1 P/Share
|
Mar 17
2025
|
David Harse General Manager Patient Care |
SELL
Payment of exercise price or tax liability
|
Direct |
1,098
-5.25%
|
$30,744
$28.1 P/Share
|
Mar 17
2025
|
Kevin Plessner General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
798
-5.6%
|
$22,344
$28.1 P/Share
|
Mar 17
2025
|
Christopher L Fowler President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
5,849
-4.09%
|
$163,772
$28.1 P/Share
|
Mar 14
2025
|
Christopher L Fowler President and CEO |
SELL
Open market or private sale
|
Direct |
5,100
-3.45%
|
$137,700
$27.02 P/Share
|
Mar 13
2025
|
Regina M. Benjamin Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,376
+10.16%
|
-
|
Mar 13
2025
|
Mark V Anquillare Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,376
+16.88%
|
-
|
Mar 13
2025
|
Amy K O'Keefe Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,376
+36.66%
|
-
|
Mar 13
2025
|
Christopher T Hjelm Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,376
+12.17%
|
-
|
Mar 13
2025
|
David A Dye Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,376
+4.25%
|
-
|
Mar 13
2025
|
Jerry G Canada Jr. Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,376
+50.0%
|
-
|
Mar 13
2025
|
Vinay Bassi Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
14,588
+23.5%
|
-
|
Mar 13
2025
|
Glenn Tobin Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,376
+7.95%
|
-
|
Mar 13
2025
|
Kevin Plessner General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
2,985
+17.31%
|
-
|
Mar 13
2025
|
Vita Mac Intyre Controller |
BUY
Grant, award, or other acquisition
|
Direct |
1,044
+28.55%
|
-
|
Mar 13
2025
|
David Harse General Manager Patient Care |
BUY
Grant, award, or other acquisition
|
Direct |
5,835
+21.83%
|
-
|
Mar 13
2025
|
Christopher L Fowler President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
22,611
+13.25%
|
-
|
Mar 13
2025
|
Andris Upitis Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,376
+50.0%
|
-
|
Mar 13
2025
|
Merideth Wilson Financial Health GM |
BUY
Grant, award, or other acquisition
|
Direct |
5,981
+50.0%
|
-
|
Mar 13
2025
|
Dawn M Severance Chief Sales Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,055
+13.75%
|
-
|
Mar 07
2025
|
Dawn M Severance Chief Sales Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
714
-1.31%
|
$19,992
$28.3 P/Share
|
Mar 07
2025
|
Christopher L Fowler President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,883
-1.13%
|
$80,724
$28.3 P/Share
|
Mar 07
2025
|
Kevin Plessner General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
517
-2.22%
|
$14,476
$28.3 P/Share
|
Feb 25
2025
|
L6 Holdings Inc. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
87,232
+4.55%
|
$2,442,496
$28.09 P/Share
|
Feb 24
2025
|
L6 Holdings Inc. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
30,377
+1.71%
|
$850,556
$28.28 P/Share
|
Feb 21
2025
|
Pinetree Capital Ltd. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
85,784
+4.77%
|
$2,401,952
$28.25 P/Share
|
Feb 20
2025
|
Pinetree Capital Ltd. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
34,952
+4.35%
|
$943,704
$27.99 P/Share
|
Feb 19
2025
|
Pinetree Capital Ltd. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
4,122
+0.56%
|
$115,416
$28.0 P/Share
|
Feb 18
2025
|
Pinetree Capital Ltd. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
6,795
+0.92%
|
$190,260
$28.16 P/Share
|
Feb 14
2025
|
Pinetree Capital Ltd. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
28,400
+3.78%
|
$766,800
$27.99 P/Share
|
Feb 13
2025
|
Pinetree Capital Ltd. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
74,981
+9.75%
|
$2,024,487
$27.61 P/Share
|